Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

145 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Molecular Targets for Biological Therapies of Severe Asthma.
Pelaia C, Crimi C, Vatrella A, Tinello C, Terracciano R, Pelaia G. Pelaia C, et al. Among authors: crimi c. Front Immunol. 2020 Nov 30;11:603312. doi: 10.3389/fimmu.2020.603312. eCollection 2020. Front Immunol. 2020. PMID: 33329598 Free PMC article. Review.
Intermittent abdominal pressure ventilation management in neuromuscular diseases: a Delphi panel Consensus.
Annunziata A, Pierucci P, Banfi PI, Carlucci A, Coppola A, Rao F, Schisano M, Simioli F, Crimi C, Esquinas AM, Karakurt Z, Mattei A, Marotta A, Bach JR, Fiorentino G. Annunziata A, et al. Among authors: crimi c. Expert Rev Respir Med. 2023 Jan-Jun;17(6):517-525. doi: 10.1080/17476348.2023.2226391. Epub 2023 Jun 21. Expert Rev Respir Med. 2023. PMID: 37323014
Point-of-care blood eosinophil count in a severe asthma clinic setting.
Heffler E, Terranova G, Chessari C, Frazzetto V, Crimi C, Fichera S, Picardi G, Nicolosi G, Porto M, Intravaia R, Crimi N. Heffler E, et al. Among authors: crimi c, crimi n. Ann Allergy Asthma Immunol. 2017 Jul;119(1):16-20. doi: 10.1016/j.anai.2017.05.016. Ann Allergy Asthma Immunol. 2017. PMID: 28668237
Bronchiectasis and asthma: a dangerous liaison?
Crimi C, Ferri S, Crimi N. Crimi C, et al. Among authors: crimi n. Curr Opin Allergy Clin Immunol. 2019 Feb;19(1):46-52. doi: 10.1097/ACI.0000000000000492. Curr Opin Allergy Clin Immunol. 2019. PMID: 30516546 Review.
Real-life rapidity of benralizumab effects in patients with severe allergic eosinophilic asthma: Assessment of blood eosinophils, symptom control, lung function and oral corticosteroid intake after the first drug dose.
Pelaia C, Busceti MT, Vatrella A, Rago GF, Crimi C, Terracciano R, Pelaia G. Pelaia C, et al. Among authors: crimi c. Pulm Pharmacol Ther. 2019 Oct;58:101830. doi: 10.1016/j.pupt.2019.101830. Epub 2019 Jul 22. Pulm Pharmacol Ther. 2019. PMID: 31344472
Adherence to omalizumab: A multicenter "real-world" study.
Campisi R, Crimi C, Intravaia R, Strano S, Noto A, Foschino MP, Valenti G, Viviano V, Pelaia C, Ricciardi L, Scichilone N, Crimi N. Campisi R, et al. Among authors: crimi c, crimi n. World Allergy Organ J. 2020 Feb 12;13(2):100103. doi: 10.1016/j.waojou.2020.100103. eCollection 2020 Feb. World Allergy Organ J. 2020. PMID: 32082464 Free PMC article.
Effects of the first three doses of benralizumab on symptom control, lung function, blood eosinophils, oral corticosteroid intake, and nasal polyps in a patient with severe allergic asthma.
Pelaia C, Busceti MT, Vatrella A, Ciriolo M, Garofalo E, Crimi C, Terracciano R, Lombardo N, Pelaia G. Pelaia C, et al. Among authors: crimi c. SAGE Open Med Case Rep. 2020 Feb 16;8:2050313X20906963. doi: 10.1177/2050313X20906963. eCollection 2020. SAGE Open Med Case Rep. 2020. PMID: 32110408 Free PMC article.
145 results